CN101128418A - 4-羟基异亮氨酸的非对映异构体及其用途 - Google Patents

4-羟基异亮氨酸的非对映异构体及其用途 Download PDF

Info

Publication number
CN101128418A
CN101128418A CNA2006800050682A CN200680005068A CN101128418A CN 101128418 A CN101128418 A CN 101128418A CN A2006800050682 A CNA2006800050682 A CN A2006800050682A CN 200680005068 A CN200680005068 A CN 200680005068A CN 101128418 A CN101128418 A CN 101128418A
Authority
CN
China
Prior art keywords
compound
pharmaceutically acceptable
diabetes
lactone
isomers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800050682A
Other languages
English (en)
Chinese (zh)
Inventor
克劳德·哥古尔立特
查尔斯·密欧斯科维他斯基
艾伦·瓦格纳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innodia Inc
Centre National de la Recherche Scientifique CNRS
Universite de Strasbourg
Original Assignee
Innodia Inc
Centre National de la Recherche Scientifique CNRS
Universite de Strasbourg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innodia Inc, Centre National de la Recherche Scientifique CNRS, Universite de Strasbourg filed Critical Innodia Inc
Publication of CN101128418A publication Critical patent/CN101128418A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNA2006800050682A 2005-02-18 2006-02-17 4-羟基异亮氨酸的非对映异构体及其用途 Pending CN101128418A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65441305P 2005-02-18 2005-02-18
US60/654,413 2005-02-18

Publications (1)

Publication Number Publication Date
CN101128418A true CN101128418A (zh) 2008-02-20

Family

ID=37086084

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800050682A Pending CN101128418A (zh) 2005-02-18 2006-02-17 4-羟基异亮氨酸的非对映异构体及其用途

Country Status (8)

Country Link
EP (1) EP1853552A2 (de)
JP (1) JP2008530198A (de)
CN (1) CN101128418A (de)
AU (1) AU2006242851A1 (de)
BR (1) BRPI0607140A2 (de)
CA (1) CA2598491A1 (de)
MX (1) MX2007009985A (de)
WO (1) WO2006117696A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112089710A (zh) * 2020-08-07 2020-12-18 郑州大学 4-羟基异亮氨酸在制备抗肿瘤药物中的应用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1874287A2 (de) * 2005-03-22 2008-01-09 Innodia Inc. Verbindungen und zusammensetzungen zur verwendung bei der vorbeugung und behandlung von fettleibigkeit und damit zusammenhängenden syndromen
WO2008154743A1 (en) * 2007-06-19 2008-12-24 Innodia Inc. Methods for the synthesis of 4-hydroxyisoleucine, stereoisomers and analogs thereof
US20110136911A1 (en) * 2007-12-20 2011-06-09 The Feinstein Institute For Medical Research Treatment of sepsis and inhibition of mif by d-t4
AU2016342027B2 (en) 2015-10-23 2021-05-13 Navitor Pharmaceuticals, Inc. Modulators of Sestrin-GATOR2 interaction and uses thereof
PL3615019T3 (pl) 2017-04-26 2026-01-19 Navitor Pharmaceuticals, Inc. Modulator interakcji sestryna-gator2 do zastosowania w leczeniu depresji opornej na leczenie
EP3870158A4 (de) 2018-10-24 2022-08-10 Navitor Pharmaceuticals, Inc. Polymorphe verbindungen und verwendungen davon
US11723890B2 (en) 2019-11-01 2023-08-15 Navitor Pharmaceuticals, Inc. Methods of treatment using an mTORC1 modulator

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2797767B1 (fr) * 1999-08-27 2002-06-14 Centre Nat Rech Scient Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances
CA2543498A1 (en) * 2003-10-27 2005-05-06 Innodia Inc. Use of hydroxylated amino acids for treating diabetes
EP1657236A1 (de) * 2004-11-10 2006-05-17 Centre National De La Recherche Scientifique (Cnrs) Verfahren zur Herstellung von Diastereoisomeren von 4-Hydroxyisoleucin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112089710A (zh) * 2020-08-07 2020-12-18 郑州大学 4-羟基异亮氨酸在制备抗肿瘤药物中的应用

Also Published As

Publication number Publication date
BRPI0607140A2 (pt) 2009-08-11
MX2007009985A (es) 2008-03-11
WO2006117696A2 (en) 2006-11-09
CA2598491A1 (en) 2006-11-09
EP1853552A2 (de) 2007-11-14
AU2006242851A1 (en) 2006-11-09
JP2008530198A (ja) 2008-08-07
WO2006117696A3 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
EP4125896B1 (de) Behandlung von typ 2 diabetes mit 2-[(4{6-((4-cyano-2-fluorbenzyl)oxy)pyridin-2-yl}piperidin-1-yl)methyl!-1-[(2s)-oxetan-2-ylmethyl)-1h-benzimidazol-6-carbonsäure oder einem pharmazeutischen salz davon
CA2586761A1 (en) Methods of treating diabetes mellitus
JP2025505198A (ja) 肥満の治療のためのｇｌｐ１受容体の活性化因子としての２－（（４－（（ｓ）－２－（４－クロロ－２－フルオロフェニル）－２－メチルベンゾ［ｄ］［１，３］ジオキソール－４－イル）ピペリジン－１－イル）メチル）－１－（（（ｓ）－オキセタン－２－イル）メチル）－１ｈ－イミダゾール誘導体
US20220152004A1 (en) Heterocyclyl(phenyl)methanol compounds useful in the treatment of hyperglycaemia
US20060199853A1 (en) Analogs of 4-hydroxyisoleucine and uses thereof
CN101128418A (zh) 4-羟基异亮氨酸的非对映异构体及其用途
EP4606798A1 (de) Benzoisothiazolverbindung sowie pharmazeutische zusammensetzung und verwendung davon
CN114929218A (zh) 使用整联蛋白抑制剂组合治疗肝脏疾病
US20060223884A1 (en) Compounds and compositions for use in the prevention and treatment of obesity and related syndromes
US20230390309A1 (en) Tetracycline derivatives for treating neurodegenerative or neuroinflammatory diseases
US12522628B2 (en) Aryl glucoside derivative and use thereof in drug
US20190231787A1 (en) Methods and compounds for treating alcohol use disorders and associated diseases
US12612427B2 (en) Aryl glucoside derivative, preparation method therefor and application thereof
HK1120255A (en) Diastereoisomers of 4-hydroxyisoleucine and uses thereof
WO2010050422A1 (ja) 糖尿病治療剤
RU2648467C2 (ru) Профилактическое или терапевтическое лекарственное средство для лечения запора
JP2025160326A (ja) 処置方法
WO2025096683A1 (en) Err modulators
WO2025096684A1 (en) Err modulators
WO2026059930A1 (en) Methods for the treatment of overweight
JP2017128545A (ja) 併用医薬
WO2015134357A1 (en) Modulators of insulin receptor
CN113387989A (zh) 一种氨基吡喃环衍生物及其在医药上的应用
WO2010120889A1 (en) Treatment of metabolic syndrome with cyclic amides
FR2887774A1 (fr) Composes de type polyphenols, les compositions les contenant et leur utilisation pour prevenir ou traiter des maladies impliquant une proliferation cellulaire anormale

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1120255

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20080220

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1120255

Country of ref document: HK